Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. MU
5. META
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015

Anika Therapeutics (ANIK) Tops Q3 EPS by 21c

October 28, 2015 5:20 PM EDT

Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.55, $0.21 better than the analyst estimate of $0.34. Revenue for the quarter came in at $23.7 million versus the consensus estimate of $22.36 million.

Our third quarter sales and profits were driven by strength in end-user demand, which together with... More